纤溶关闭与创伤患者缺乏组织型纤溶酶原激活剂超敏性时死亡率增加五倍相关
该研究为单中心创伤激活队列,2014至2016年纳入伤后1小时内采血的398例患者(中位新损伤严重度评分18),用快速血栓弹力图(r-TEG)及外源性t-PA修饰TEG(t-TEG)将患者分为六种纤溶表型。纤溶关闭死亡率最高(20%),其次为纤溶亢进(16%)和生理性纤溶(9%,p=0.020)。在非t-PA超敏队列中,纤溶关闭患者死亡率15%,非纤溶关闭患者3%(p=0.003),校正损伤严重度评分与年龄后仍显著(p=0.033)。总体t-PA活性(p=0.002)、PAI-1(p<0.001)及t-PA/PAI-1复合物水平(p=0.006)在六种表型间存在差异,分析的19种纤溶调节蛋白中54%显著不同。
要点
- 创伤患者中纤溶关闭(r-TEG LY30<0.9%)死亡率20%,高于纤溶亢进16%和生理性纤溶9%(p=0.020)。
- 非t-PA超敏患者中,纤溶关闭死亡率15% vs 非纤溶关闭3%(p=0.003),校正损伤严重度评分与年龄后仍显著(p=0.033)。
- t-PA超敏(t-TEG LY30大于健康志愿者95百分位)见于27%的患者,用于细分六种纤溶表型。
- 六种表型间总体t-PA活性(p=0.002)、PAI-1(p<0.001)、t-PA/PAI-1复合物(p=0.006)存在差异,54%的纤溶调节蛋白(19种中)显著不同。
- 作者结论认为急性纤溶关闭并非单一病因所致,且与PAI-1活性明确相关,不同表型需进一步研究以确定最佳复苏策略。
适用人群与场景
- 2014至2016年本中心一级创伤中心创伤激活患者,伤后1小时内采血。
- 纳入398例患者,中位新损伤严重度评分18。
诊断标准与关键阈值
- 采用r-TEG LY30阈值分层:纤溶关闭<0.9%,生理性纤溶0.9-2.9%,纤溶亢进>2.9%。
- t-TEG LY30大于健康志愿者(n=140)95百分位定义为t-PA超敏。
- 根据r-TEG与t-TEG结果将患者分为六种纤溶表型。
研究设计与关键结果
- 研究设计:单中心创伤激活队列,2014至2016年,398例患者,中位新损伤严重度评分18,伤后1小时内采血行r-TEG及t-TEG检测。
- 主要结果:纤溶关闭死亡率20%,纤溶亢进16%,生理性纤溶9%(p=0.020)。
- 非t-PA超敏队列:纤溶关闭死亡率15% vs 非纤溶关闭3%(p=0.003);校正损伤严重度评分与年龄后仍显著(p=0.033)。
- t-PA超敏见于27%的患者。
- 六种表型间总体t-PA活性(p=0.002)、PAI-1(p<0.001)、t-PA/PAI-1复合物(p=0.006)存在差异;分析的19种纤溶调节蛋白中54%显著不同。
证据类型、等级与局限
- 证据类型:预后研究,证据等级III级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对创伤患者行r-TEG检测有助于识别纤溶关闭表型(LY30<0.9%),该表型在非t-PA超敏患者中死亡率显著升高(15% vs 3%,p=0.003;校正后p=0.033)。
- 作者认为急性纤溶关闭并非单一病因,且与PAI-1活性明确相关。
- 作者认为不同表型需进一步研究以确定这些患者的最佳复苏策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Fibrinolysis shutdown (SD) is an independent risk factor for increased mortality in trauma. High levels of plasminogen activator inhibitor-1 (PAI-1) directly binding tissue plasminogen activator (t-PA) is a proposed mechanism for SD; however, patients with low PAI-1 levels present to the hospital with a rapid TEG (r-TEG) LY30 suggestive SD. We therefore hypothesized that two distinct phenotypes of SD exist, one, which is driven by t-PA inhibition, whereas another is due to an inadequate t-PA release in response to injury.
METHODS: Trauma activations from our Level I center between 2014 and 2016 with blood collected within an hour of injury were analyzed with r-TEG and a modified TEG assay to quantify fibrinolysis sensitivity using exogenous t-PA (t-TEG). Using the existing r-TEG thresholds for SD (<0.9%), physiologic (LY30 0.9-2.9%), and hyperfibrinolysis (LY30 > 2.9%) patients were stratified into phenotypes. A t-TEG LY30 greater than 95th percentile of healthy volunteers (n = 140) was classified as t-PA hypersensitive and used to subdivide phenotypes. A nested cohort had t-PA and PAI-1 activity levels measured in addition to proteomic analysis of additional fibrinolytic regulators.
RESULTS: This study included 398 patients (median New Injury Severity Score, 18), t-PA-Sen was present in 27% of patients. Shutdown had the highest mortality rate (20%) followed by hyperfibinolysis (16%) and physiologic (9% p = 0.020). In the non-t-PA hypersensitive cohort, SD had a fivefold increase in mortality (15%) compared with non-SD patients (3%; p = 0.003) which remained significant after adjusting for Injury Severity Score and age (p = 0.033). Overall t-PA activity (p = 0.002), PAI-1 (p < 0.001), and t-PA/PAI-1 complex levels (p = 0.006) differed between the six phenotypes, and 54% of fibrinolytic regulator proteins analyzed (n = 19) were significantly different.
CONCLUSION: In conclusion, acute fibrinolysis SD is not caused by a single etiology, and is clearly associated with PAI-1 activity. The differential phenotypes require an ongoing investigation to identify the optimal resuscitation strategy for these patients.
LEVEL OF EVIDENCE: Prognostic, level III.
参考来源
- Moore HB, Moore EE, Huebner BR, et al. Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator. J Trauma Acute Care Surg. 2017. PMID: 29190254. doi:10.1097/TA.0000000000001718
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。